115
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Clinical Outcome in Soft Tissue Sarcoma Patients with Lung Metastasis Who Received Metastasectomy and/or Radiofrequency Ablation: Tokai Musculoskeletal Oncology Consortium Study

ORCID Icon, ORCID Icon, ORCID Icon, , , , , , , , , , , , , , , ORCID Icon & ORCID Icon show all
Pages 8473-8480 | Published online: 10 Nov 2021

References

  • Bourcier K, Le Cense A, Tselikas L, et al. Basic knowledge in soft tissue sarcoma. Cardiovasc Intervent Radiol. 2019;42(9):1255–1261. doi:10.1007/s00270-019-02259-w31236647
  • Stamenovic D, Hohenberger P, Roessner E. Pulmonary metastasectomy in soft tissue sarcomas: a systematic review. J Thorac Dis. 2021;13(4):2649–2660. doi:10.21037/jtd-2019-pm-1334012614
  • Nakamura T, Matsumine A, Takao M, et al. Impact of tumor volume doubling time on post-metastatic survival in bone and soft- tissue sarcoma patients treated with metastasectomy and/or radiofrequency ablation of the lung. Onco Targets Ther. 2017;10:559–564. doi:10.2147/OTT.S12156228203089
  • Marulli G, Mammana M, Comacchio G, Rea F. Survival and prognostic factors following pulmonary metastasectomy for sarcoma. J Thorac Dis. 2017;9(Suppl 12):S1305–S1315. doi:10.21037/jtd.2017.03.17729119019
  • Nakamura T, Matsumine A, Yamakado K, et al. Lung radiofrequency ablation in patients with pulmonary metastases from musculoskeletal sarcomas. Cancer. 2009;115(16):3774–3781. doi:10.1002/cncr.2442019514086
  • Koelblinger C, Strauss S, Gillams A. Outcome after radiofrequency ablation of sarcoma lung metastases. Cardiovasc Intervent Radiol. 2014;37(1):147–153. doi:10.1007/s00270-013-0644-923670570
  • Nevala R, Jaamaa S, Tukuainen E, et al. Long-term results of surgical resection of lung metastases from soft tissue sarcoma: a single center experience. J Surg Oncol. 2019;120(2):168–175.31134646
  • Chudgar NP, Brennan MF, Munhoz RR, et al. Pulmonary metastasectomy with therapeutic intent for soft-tissue sarcoma. J Thorac Cardiovasc Surg. 2017;154(1):319–330.e1. doi:10.1016/j.jtcvs.2017.02.06128395901
  • Van Geel AN, Pastorino U, Jauch KW, et al. Surgical treatment of lung metastases: the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group study of 255 patients. Cancer. 1996;77(4):675–682. doi:10.1002/(SICI)1097-0142(19960215)77:4<675::AID-CNCR13>3.0.CO;2-Y8616759
  • Yamamoto Y, Kanzaki R, Kanou T, et al. Long-term outcomes and prognostic factors of pulmonary metastasectomy for osteosarcoma and soft tissue sarcoma. Int J Clin Oncol. 2019;24(7):863–870. doi:10.1007/s10147-019-01422-030806840
  • Suzuki M, Iwata T, Ando S, et al. Predictors of long-term survival with pulmonary metastasectomy for osteosarcoma and soft tissue sarcomas. J Cardiovasc Surg (Torino). 2006;47(5):603–608.
  • Predina JD, Puc MM, Bergey MR, et al. Improved survival after pulmonary metastasectomy for soft tissue sarcoma. J Thorac Oncol. 2011;6(5):913–919. doi:10.1097/JTO.0b013e3182106f5c21750417
  • Sanderberg RA, Figueiredo LP, Haddad FJ, Gross JL, Younes RN. Pulmonary metastasectomy from soft tissue sarcomas. Clinics. 2010;65(9):871–876. doi:10.1590/S1807-5932201000090001021049215
  • Rhhders A, Hosch SB, Scheunemann P, Stoeklein NH, Knoefel WT, Peiper M. Benefit of surgical treatment of lung metastasis in soft tissue sarcoma. Arch Surg. 2007;142(1):70–75. doi:10.1001/archsurg.142.1.7017224503
  • Nakamura T, Matsumine A, Matsubara T, Asanuma K, Uchida A, Sudo A. Clinical impact of the tumor volume doubling time on sarcoma patients with lung metastases. Clin Exp Metastasis. 2011;28(8):819–825. doi:10.1007/s10585-011-9413-921805254
  • Carter RJ, Qin LX, Downey RJ, Brennan MF, Singer S, Maki RG. Perioperative chemotherapy in patients undergoing pulmonary resection for metastatic soft-tissue sarcoma of the extremity. Cancer. 2007;110(9):2050–2060. doi:10.1002/cncr.2302317828771
  • Greenwood A, West D. Is a thoracotomy rather than thoracoscopic resection associated with improved survival after pulmonary metastasectomy? Interact Cardiovasc Thorac Surg. 2013;17(4):720–724. doi:10.1093/icvts/ivt30023832919
  • Nakamura T, Asanuma K, Hagi T, Sudo A. Clinical outcome of systemic treatment for advanced soft tissue sarcoma: real-life perspective in Japan. Drug Des Devel Ther. 2020;14:4215–4220. doi:10.2147/DDDT.S275526